HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased frequency of CD45 negative T cells (T zone cells) in older Golden retriever dogs.

Abstract
T zone lymphoma (TZL) is characterized by the clonal expansion of T cells lacking expression of the pan-leukocyte antigen CD45 (TZ cells). A strong breed predisposition is observed in Golden retrievers. This study aimed to confirm aberrant CD45 mRNA expression and determine if Golden retrievers without clinical lymphoma have an increased frequency of circulating TZ cells. Gene expression analysis on confirmed TZL cases showed a significant decrease in CD45 expression compared to normal dogs. Peripheral blood samples from senior dogs, 242 Golden retrievers and 42 non-Golden retrievers, without evidence of lymphoproliferative disease were assessed for the presence of TZ cells by flow cytometry. Thirty-one percent of Golden retrievers had TZ cells compared to 14% of non-Golden retrievers. Thirty-four percent of Golden retrievers with TZ cells had a clonal T cell receptor gamma (TRG) gene rearrangement. Interestingly, 20% of Golden retrievers without TZ cells also had a clonal TRG rearrangement. Golden retrievers may have an increased risk of TZL due to an increased frequency of TZ cells.
AuthorsK L Hughes, J D Labadie, J A Yoshimoto, J J Dossey, R C Burnett, A C Avery
JournalVeterinary and comparative oncology (Vet Comp Oncol) Vol. 16 Issue 1 Pg. E109-E116 (Mar 2018) ISSN: 1476-5829 [Electronic] England
PMID28905476 (Publication Type: Journal Article)
Copyright© 2017 John Wiley & Sons Ltd.
Chemical References
  • Receptors, Antigen, T-Cell, gamma-delta
  • Leukocyte Common Antigens
Topics
  • Aging
  • Animals
  • Dogs (genetics, metabolism)
  • Female
  • Flow Cytometry (veterinary)
  • Leukocyte Common Antigens (metabolism)
  • Lymphocyte Count (veterinary)
  • Male
  • Receptors, Antigen, T-Cell, gamma-delta (genetics)
  • Species Specificity
  • T-Lymphocytes (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: